Compassionate Use of Domperidone for Refractory Gastroparesis
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this program is to allow the use of domperidone in children from 12 to 21
years of age with symptoms related to motility disorders and Gastroesophageal reflux disease
(GERD) who have failed all the standard treatments for their condition.